Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pucotenlimab”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07800000
What this trial is testing

Becotatug Vedotin Plus Pucotenlimab and Capecitabine Followed by Concurrent Chemoradiotherapy-Immunotherapy for Locally Advanced Squamous Cell Carcinoma of the Anal Canal

Who this might be right for
Squamous Cell Carcinoma of the Anal Canal
Wang Xin 34
Testing effectiveness (Phase 2)Looking for participantsNCT07814287
What this trial is testing

Becotatug Vedotin Plus Pucotenlimab and Platinum Chemotherapy in Locally Advanced Epidermal Growth Factor Receptor (EGFR)-Positive Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma, HNSCC
Xuekui Liu 40
Testing effectiveness (Phase 2)Looking for participantsNCT07312422
What this trial is testing

LDRT Combined With Pucotenlimab and Standard Therapy for Advanced Pancreatic Cancer: A Single-Arm Study

Who this might be right for
Pancreatic CancerPD-L1PD-1 Inhibitor+2 more
Zhejiang Provincial People's Hospital 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07707167
What this trial is testing

A Prospective, Exploratory Study of Becotatug Vedotin Plus Putlimab for Neoadjuvant Therapy and Adjuvant Radiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
LA HNSCC
Jiangsu Cancer Institute & Hospital 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07381699
What this trial is testing

MRG003 Combined With Immunotherapy in Recurrent/Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
West China Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07353827
What this trial is testing

FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)Hepatic Arterial Infusion Chemotherapy
Sun Yat-sen University 36
Testing effectiveness (Phase 2)Looking for participantsNCT06969534
What this trial is testing

Safety and Efficacy of Pucotenlimab in pLECC

Who this might be right for
Lymphoepithelioma-like CarcinomaLymphoepitheliomaCarcinoma
Sun Yat-sen University 33
Testing effectiveness (Phase 2)Looking for participantsNCT07632339
What this trial is testing

Becotatug Vedotin Combined With Pucotenlimab for Locally Recurrent Resectable Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Cancer
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 102
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07393477
What this trial is testing

Neoadjuvant Becotatug Vedotin Plus Pucotenlimab and Cisplatin for Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell CarcinomaHead and Neck Squamous Cell Carcinoma HNSCC
Sir Run Run Shaw Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT07665190
What this trial is testing

Neoadjuvant EGFR-ADC Combined With Anti-PD-1 Monoclonal Antibody in Resectable Locally Advanced Hypopharyngeal Squamous Cell Carcinoma

Who this might be right for
Hypopharyngeal Squamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital 52
Not applicableNot Yet RecruitingNCT07092449
What this trial is testing

Pucotenlimab Combined With Chemotherapy as Perioperative Treatment for Locally Advanced Gastroesophageal Junction Carcinoma

Who this might be right for
Gastroesophageal JunctionGastric / Gastroesophageal Junction AdenocarcinomaNeoadjuvant Chemoimmunotherapy+1 more
Tang-Du Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT06192797
What this trial is testing

Combined HAIC, Lenvatinib and Pucotenlimab as Conversion Therapy for Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma Non-resectable
Tongji Hospital 36
Testing effectiveness (Phase 2)Looking for participantsNCT07712029
What this trial is testing

Phase II Study of Becotatug Vedotin Plus Pucotenlimab for Advanced Refractory Solid Tumors With EGFR-Positive

Who this might be right for
Advanced Refractory Solid TumorsEGFR Gene Overexpression
Tianjin Medical University Second Hospital 32
Large-scale testing (Phase 3)Not Yet RecruitingNCT07524413
What this trial is testing

Becotatug Vedotin (MRG003) With PD-1 Blockade and Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)Nasopharyngeal Cancer
Sun Yat-sen University 514
Testing effectiveness (Phase 2)Looking for participantsNCT07497919
What this trial is testing

Becotatug Vedotin Combined With Pucotenlimab in the Treatment of EGFR-Positive Advanced Penile Cancer

Who this might be right for
Penile Cancer
Fudan University 20
Testing effectiveness (Phase 2)Looking for participantsNCT07235566
What this trial is testing

MRG003 and Pucotenlimab to Treat Locally Advanced or Metastatic ATC/PDTC

Who this might be right for
Thyroid Cancer
Fudan University 60
Testing effectiveness (Phase 2)Looking for participantsNCT07750067
What this trial is testing

Tunlametinib in Combination With Pucotenlimab and Hydroxychloroquine in NRAS Mutant Melanoma

Who this might be right for
Melanoma MetastaticNRAS Mutation
Sun Yat-sen University 37
Testing effectiveness (Phase 2)Looking for participantsNCT07105852
What this trial is testing

Exploring the Safety and Efficacy of Sacituzumab Tirumotecan Combined With Pucotenlimab in the Treatment of Advanced Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Sir Run Run Shaw Hospital 59
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06869174
What this trial is testing

Pucotenlimab Combined with MRG002 for HER2-positive Cancer of Unknown Primary

Who this might be right for
Cancer of Unknown Primary
Zhiguo Luo, MD, PhD 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07692334
What this trial is testing

Becotatugvedotin Plus Pucotenlimab in EGFR-Positive Advanced Gastric/GEJ Adenocarcinoma

Who this might be right for
Gastric CancerGastroesophageal Junction (GEJ) AdenocarcinomaBecotatug Vedotin+1 more
West China Second University Hospital 28
Next Page